The Federal Trade Commission didn’t contest Amazon’s $3.9 billion deal for primary care company One Medical despite agency officials’ beliefs that the acquisition would hurt competition, Politico reported March 20.
Read the full post on Becker's Hospital Review - Healthcare News
